Author: Peter Stavropoulos

On Aug. 12, 2016, the United States Drug Enforcement Agency denied a petition to initiate the rescheduling of marijuana from a Schedule I to a Schedule II substance. Despite recent outcry from many within the industry, this should not be considered a blow to the cannabis industry in the United States. This was in fact…